Interested in the current standard of care (SOC) treatments for ATK and BTK lesions?

See the clinical outcomes for standard of care3

This study establishes the baseline for BIO-OSCAR FIRST study, which aims to confirm the effectiveness of Oscar®.

Your information will be processed in accordance with our privacy statement.

Please note that you can withdraw your consent at any time by using the unsubscribe option in our emails.

 *indicates required field